Tag:
Medtronic
Latest Headlines
Latest Headlines
Studies: Medtronic's Infuse offers mild benefit, significant risk
Medtronic's much-scrutinized Infuse spinal implant performs no better than traditional bone grafts and carries an increased risk of cancer, sterility and other side effects, according to two independent reviews.
UPDATED: German court upholds Medtronic's CoreValve heart pump patent
Some observers were predicting defeat. But in German court, at least, Medtronic came out ahead in its heart pump patent battle with Edwards Lifesciences.
MC10 pushes wearable sensors with Medtronic co-sign
Massachusetts' MC10 has developed a stretchable, sensor-laden technology you can wear, allowing for vital readings on the go, and with big-name backers like Medtronic and Reebok, the company believes its innovation could revolutionize mobile health.
FDA joins chorus of concern about cybersecurity threats
The FDA jumped off the sidelines in the ongoing discussion about threats to networked medical devices, issuing draft guidance to manufacturers and others to take additional precautions against cyberattacks that endanger patients.
Medtronic launches spinal surgery tool in Europe
Medtronic is debuting a new surgical tool in Europe designed to help surgeons perform osteotomies to treat severe spinal curvature in adults. The launch comes in tandem with a new CE mark.
NuVasive ordered to pay Medtronic royalties in spinal implant suit
Medtronic may be at risk of losing big in a patent battle with one company, but the Minnesota device giant is on the winning side of another dustup with a different rival, at least for now.
Analyst: German court 60% likely to halt Medtronic's CoreValve sales
Expect Edwards Lifesciences' aggressive and increasingly hard-core heart valve patent battle with Medtronic to get worse in the coming weeks. An industry analyst predicts that a German court will issue an injunction preventing Medtronic from selling its CoreValve transcatheter aortic valve replacement in that country. And continued legal action is advancing in the U.S.
1 year later, J&J exec admits Synthes M&A is less than 50% done
A year after Johnson & Johnson snatched up Swiss orthopedic devicemaker Synthes for an astounding $21.3 billion, the merging of operations is incredibly slow-going and has cost the combined company some business and research talent, the Swiss publication Finanz und Wirtschaft ( Finance and Economics ) reports.
Bard's drug-coated balloon begins 'below-the-knee' PAD trial
C.R. Bard is working hard to show the versatility of its Lutonix drug-coated balloon, even before it wins FDA approval. A few years after acquiring the technology in a $225 million grab of a company with the same name, the first human patient has joined a new trial testing the device below the knee.
Medtronic wins FDA nod, CE mark for angioplasty balloon
Medtronic is expanding its presence in peripheral artery disease, winning FDA clearance and a CE mark for the Pacific Plus balloon catheter, a next-generation vascular treatment.
